An open label double arm randomized clinical comparative study to evaluate the efficacy of krushnadya taila nasya along with mahatriphaladi ghrita tarpana and mahatriphaladi ghrita tarpana in prathama patala gata timira w s r myopic astigmatism
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- To asceses the improvement in vision . Snellen’s chart
Study Overview
Brief Summary
In Ayurveda, Vataja Timira is known for producing symptoms such as avyakta darshana(difficulty in seeing distant objects) seen in myopic astigmatism. As Vata dosha is implicated in timira, therapies aimed at pacifying Vata are considered most appropriate. Snehana (oleation therapy) regarded as the primary treatment for this condition has been selected for this study. Ayurveda also describes effective procedures for Timira, including Virechana (purgation), Kriyakalpas(ocular procedures), and Nasya (nasal administration). Among these, Tarpanahas been specifically highlighted in classical texts as a beneficial therapy fortimiraand enhancing visual function. The formulation Mahatriphaladi Ghrita, mentioned in Ashtanga Hridaya, is said to alleviate a wide range of ocular disorders when used as Tarpana.To enhance the therapeutic potential,Krushnadya Taila Nasya is selected . This formulation is mentioned in Chakradattaand also in Yogaratnakara, where it is described as highly effective in the treatment of Timira.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 10.00 Year(s) to 30.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients with clinical features of Prathama patalagata Timira Patients with clinical features of simple or compound Myopic Astigmatism.
- •Patient of either gender within the age group of 10-30 years.
- •Visual acuity up to 6/12 .
- •Patient of best corrected vision with cylindrical lens up to -1D with or without spherical -2D.
- •Patient who is fit for Nasya and Tarpana procedure.
Exclusion Criteria
- •Patient with other ocular diseases like keratoconus, cataract, squint, glaucoma, retinal diseases Patients with systemic conditions affecting the eye and secondary myopia e.g diabetes mellitus, connective tissue disorders.
- •Patient with history of ocular trauma or surgery Pregenent women and lactating mothers .
Outcomes
Primary Outcomes
To asceses the improvement in vision . Snellen’s chart
Time Frame: Total duration of study is 14 days nasya and tarpana for 7 days and follow up after 1 week
Secondary Outcomes
No secondary outcomes reported
Investigators
Dr Nagaraj s itagi
sri kalabyraveswara swamy ayurvedic medical college hospital and research centre banglore